Literature DB >> 29435911

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.

Amir Sarayani1,2, Mojgan Mashayekhi3, Marzieh Nosrati3, Zahra Jahangard-Rafsanjani4, Mohammadreza Javadi1,4, Navid Saadat5, Sheyda Najafi3, Kheirollah Gholami6,7.   

Abstract

Background Pharmacists' interventions to improve outcomes of diabetes management have been promising. However, evidence on using telephone-based interventions in pharmacy practice are limited, particularly in developing countries. Objective To evaluate the efficacy of a telephone-based intervention to improve care and clinical outcomes in type-2 diabetes. Setting A referral community pharmacy and drug information center. Method We conducted a two-armed randomized controlled trial on 100 patients with type-2 diabetes. The intervention consisted of 16 telephone calls in 3 month by a trained pharmacist working in an academic drug information center, while the control group received usual care. Before random allocation, patients attended a live education session delivered by pharmacists to learn the basics of diabetes care and to confirm the eligibility criteria. Assessments were performed at baseline, month-3 (after intervention), and month-9 (follow-up). Main outcome measure Hemoglobin A1c (HbA1c). Results Eighty four patient completed the trial. Baseline variables were comparable between the two groups and the baseline value of hemoglobin A1c was 8.00 ± 1.44 in the study population. HbA1c was significantly improved in both groups at month-3 (6.97 ± 1.41 vs. 7.09 ± 1.78) and remained steady at month-9 (6.96 ± 1.44 vs. 7.26 ± 1.85). Lipid profile showed small improvements in the intervention group but was not significant. The adherence score and self-care score improvement was significantly higher in the intervention group at month-3 and were maintained at month-9. Conclusion Medication adherence and self-care significantly improved in the telephone-based intervention group. However, the improvement of clinical outcomes might have been diluted due to the live diabetes education session.

Entities:  

Keywords:  Diabetes Type-2; Diabetes education; HbA1c; Iran; Medication adherence; Pharmacist; Self-care; Telephone counseling

Mesh:

Year:  2018        PMID: 29435911     DOI: 10.1007/s11096-018-0593-0

Source DB:  PubMed          Journal:  Int J Clin Pharm


  40 in total

1.  Effect of telephone follow-up on adherence to a diabetes therapeutic regimen.

Authors:  Maryam Nesari; Masoumeh Zakerimoghadam; Asadollah Rajab; Shiva Bassampour; Soghrat Faghihzadeh
Journal:  Jpn J Nurs Sci       Date:  2010-12       Impact factor: 1.418

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes.

Authors:  Russell Rothman; Robb Malone; Betsy Bryant; Cheryl Horlen; Michael Pignone
Journal:  Am J Med Qual       Date:  2003 Mar-Apr       Impact factor: 1.852

Review 4.  Diabetes management via mobile phones: a systematic review.

Authors:  Bree Holtz; Carolyn Lauckner
Journal:  Telemed J E Health       Date:  2012-02-22       Impact factor: 3.536

5.  Diabetes Ten City Challenge: final economic and clinical results.

Authors:  Toni Fera; Benjamin M Bluml; William M Ellis
Journal:  J Am Pharm Assoc (2003)       Date:  2009 May-Jun

6.  Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies.

Authors:  Andy Menke; Keith F Rust; Judith Fradkin; Yiling J Cheng; Catherine C Cowie
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

Review 7.  Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review.

Authors:  Deborah P Wubben; Eva M Vivian
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

8.  The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Authors:  I Krass; C L Armour; B Mitchell; M Brillant; R Dienaar; J Hughes; P Lau; G Peterson; K Stewart; S Taylor; J Wilkinson
Journal:  Diabet Med       Date:  2007-06       Impact factor: 4.359

9.  The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.

Authors:  Sarah Stark Casagrande; Judith E Fradkin; Sharon H Saydah; Keith F Rust; Catherine C Cowie
Journal:  Diabetes Care       Date:  2013-02-15       Impact factor: 19.112

10.  A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research.

Authors:  Amir Sarayani; Zahra Jahangard-Rafsanjani; Molouk Hadjibabaie; Alireza Ahmadvand; Mohammadreza Javadi; Kheirollah Gholami
Journal:  J Diabetes Metab Disord       Date:  2013-12-20
View more
  14 in total

1.  A physician-pharmacist collaborative care model to prevent opioid misuse.

Authors:  Pooja Lagisetty; Alex Smith; Derek Antoku; Suzanne Winter; Michael Smith; Mary Jannausch; Hae Mi Choe; Amy S B Bohnert; Michele Heisler
Journal:  Am J Health Syst Pharm       Date:  2020-05-07       Impact factor: 2.637

Review 2.  The Effect of Interventions Led by Community Pharmacists in Primary Care for Adults with Type 2 Diabetes Mellitus on Therapeutic Adherence and HbA1c Levels: A Systematic Review.

Authors:  Sarah Al Assaf; Romana Zelko; Balazs Hanko
Journal:  Int J Environ Res Public Health       Date:  2022-05-19       Impact factor: 4.614

Review 3.  Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c.

Authors:  Ana Paula Delgado Bomtempo Batalha; Isabela Coelho Ponciano; Gabriela Chaves; Diogo Carvalho Felício; Raquel Rodrigues Britto; Lilian Pinto da Silva
Journal:  J Diabetes Metab Disord       Date:  2021-07-15

4.  Care management intervention to strengthen self-care of multimorbid patients with type 2 diabetes in a German primary care network: A randomized controlled trial.

Authors:  Dominik Ose; Martina Kamradt; Marion Kiel; Tobias Freund; Werner Besier; Manfred Mayer; Johannes Krisam; Michel Wensing; Hans-Joachim Salize; Joachim Szecsenyi
Journal:  PLoS One       Date:  2019-06-12       Impact factor: 3.240

5.  Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes.

Authors:  Fang Liz Zhou; Jason Yeaw; Swapna U Karkare; Mitch DeKoven; Paulos Berhanu; Timothy Reid
Journal:  BMJ Open Diabetes Res Care       Date:  2018-12-22

Review 6.  Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta-Review.

Authors:  Claudia Eberle; Stefanie Stichling
Journal:  J Med Internet Res       Date:  2021-02-17       Impact factor: 5.428

Review 7.  Telemedicine to deliver diabetes care in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Jorge César Correia; Hafsa Meraj; Soo Huat Teoh; Ahmed Waqas; Maaz Ahmad; Luis Velez Lapão; Zoltan Pataky; Alain Golay
Journal:  Bull World Health Organ       Date:  2020-11-29       Impact factor: 9.408

Review 8.  Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis.

Authors:  Yaqian Mao; Wei Lin; Junping Wen; Gang Chen
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

9.  Health system interventions for adults with type 2 diabetes in low- and middle-income countries: A systematic review and meta-analysis.

Authors:  David Flood; Jessica Hane; Matthew Dunn; Sarah Jane Brown; Bradley H Wagenaar; Elizabeth A Rogers; Michele Heisler; Peter Rohloff; Vineet Chopra
Journal:  PLoS Med       Date:  2020-11-12       Impact factor: 11.613

10.  Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.

Authors:  Elizabeth A Kobe; David Edelman; Phillip E Tarkington; Hayden B Bosworth; Matthew L Maciejewski; Karen Steinhauser; Amy S Jeffreys; Cynthia J Coffman; Valerie A Smith; Elizabeth M Strawbridge; Steven T Szabo; Shivan Desai; Mary P Garrett; Theresa C Wilmot; Teresa J Marcano; Donna L Overby; Glenda A Tisdale; Melissa Durkee; Susan Bullard; Moahad S Dar; Amy C Mundy; Janette Hiner; Sonja K Fredrickson; Nadya T Majette Elliott; Teresa Howard; Deborah H Jeter; Susanne Danus; Matthew J Crowley
Journal:  Contemp Clin Trials       Date:  2020-09-21       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.